Gelteq Limited (GELS)
NASDAQ: GELS · Real-Time Price · USD
1.040
-0.100 (-8.77%)
At close: Jun 18, 2026, 4:00 PM EDT
1.030
-0.010 (-0.96%)
After-hours: Jun 18, 2026, 7:57 PM EDT
Gelteq Revenue
In the fiscal year ending June 30, 2025, Gelteq had annual revenue of 413.13K AUD with 188.27% growth. Gelteq had revenue of 101.72K in the half year ending June 30, 2025.
Revenue (ttm)
413.13K AUD
Revenue Growth
+188.27%
P/S Ratio
41.13
Revenue / Employee
51,642 AUD
Employees
8
Market Cap
11.14M USD
Revenue Chart
* This company reports financials in AUD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 413.13K | 269.82K | 188.27% |
| Jun 30, 2024 | 143.31K | -199.59K | -58.21% |
| Jun 30, 2023 | 342.90K | -29.17K | -7.84% |
| Jun 30, 2022 | 372.07K | 212.20K | 132.73% |
| Jun 30, 2021 | 159.87K | - | - |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Rockwell Medical | 67.68M |
| Aytu BioPharma | 56.60M |
| Biofrontera | 43.20M |
| cbdMD | 19.98M |
| InMed Pharmaceuticals | 4.94M |
| TherapeuticsMD | 3.35M |
| China SXT Pharmaceuticals | 1.54M |
| Akanda | 258.08K |
GELS News
- 1 day ago - Gelteq Provides Corporate Update: Launching Veterinary and Human Clinical Trials, Pharmaceutical Pipeline Expanding Across Multiple Programs - GlobeNewsWire
- 6 days ago - Gelteq Successfully Completes Veterinary Palatability Trials with Kemin, Further Validating Gelteq® Technology for Animal Health Applications - GlobeNewsWire
- 14 days ago - Gelteq Establishes Center of Excellence in China to Accelerate Product Development and Commercial Expansion - GlobeNewsWire
- 4 weeks ago - Gelteq Commences Veterinary Medicine Clinical Trial to Support an FDA Regulatory Pathway - GlobeNewsWire
- 5 weeks ago - Healthy Extracts Q1 2026 Net Revenue Up 73% to Record $1.6 Million, Driving Positive EBITDA - Accesswire
- 5 weeks ago - Gelteq Announces USD $3.5 Million Strategic Debt Financing to Accelerate Commercialization and Support Revenue Growth - GlobeNewsWire
- 2 months ago - Healthy Extracts Reports 2025 Net Revenue Up 45% to Record $4.5 Million - Accesswire
- 2 months ago - Healthy Extracts Reports Preliminary 2025 Results, Net Revenue Expected Up 45% to Record $4.5 Million - Accesswire